NMPA Approval

复方乌槟颗粒

Approval Number

国药准字Z20070038

Company丽珠集团利民制药厂

Registration Date

August 26, 2021

Previous Approval Numbers

国药准字Z20070038

Drug Information

Generic Name

复方乌槟颗粒

Dosage Form

颗粒剂

Strength

每袋装7g

Drug Type

中药

Registration Date

August 26, 2021

Company Information

Applicant Company

Company Name丽珠集团利民制药厂

Company Address

广东省韶关市工业西路89号

Manufacturing Company

Company Name丽珠集团利民制药厂

Company Address

广东省韶关市工业西路89号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方乌槟颗粒 - NMPA 批准文号 | MedPath